dupixent - dupilumab injection, solution
(Dupilumab)Sanofi-Aventis U.S. Llc
Usage: DUPIXENT treats moderate-to-severe atopic dermatitis (6 months+), asthma (6 years+), chronic rhinosinusitis with nasal polyps (12 years+), eosinophilic esophagitis (1 year+), prurigo nodularis, COPD, chronic spontaneous urticaria (12 years+), bullous pemphigoid, and allergic fungal rhinosinusitis in eligible adult and pediatric patients.